JOP20200104A1 - مركبات مثبطة لـ btk - Google Patents
مركبات مثبطة لـ btkInfo
- Publication number
- JOP20200104A1 JOP20200104A1 JOP/2020/0104A JOP20200104A JOP20200104A1 JO P20200104 A1 JOP20200104 A1 JO P20200104A1 JO P20200104 A JOP20200104 A JO P20200104A JO P20200104 A1 JOP20200104 A1 JO P20200104A1
- Authority
- JO
- Jordan
- Prior art keywords
- btk inhibitor
- inhibitor compounds
- compounds
- salts
- compositions
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Pain & Pain Management (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
يوفر الاختراع مركبات مثبطة لـ BTK، أملاح مقبولة صيدليًا، تركيبات صيدلية مما سبق، وطرق استخدام هذه المركبات، الأملاح، أو تركيبات لعلاج أمراض المناعة الذاتية مثل التهاب المفاصل الروماتيدي.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201762581967P | 2017-11-06 | 2017-11-06 | |
PCT/US2018/058104 WO2019089512A1 (en) | 2017-11-06 | 2018-10-30 | Btk inhibitor compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
JOP20200104A1 true JOP20200104A1 (ar) | 2022-10-30 |
Family
ID=64277913
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JOP/2020/0104A JOP20200104A1 (ar) | 2017-11-06 | 2018-10-30 | مركبات مثبطة لـ btk |
Country Status (34)
Country | Link |
---|---|
US (1) | US11542249B2 (ar) |
EP (1) | EP3707133B1 (ar) |
JP (1) | JP6920553B2 (ar) |
KR (1) | KR102410202B1 (ar) |
CN (1) | CN111278818B (ar) |
AR (1) | AR113796A1 (ar) |
AU (1) | AU2018360478B2 (ar) |
BR (1) | BR112020006749A2 (ar) |
CA (1) | CA3080123C (ar) |
CL (1) | CL2020001089A1 (ar) |
CR (1) | CR20200183A (ar) |
CY (1) | CY1124994T1 (ar) |
DK (1) | DK3707133T3 (ar) |
DO (1) | DOP2020000103A (ar) |
EA (1) | EA039398B1 (ar) |
EC (1) | ECSP20024395A (ar) |
ES (1) | ES2904843T3 (ar) |
HR (1) | HRP20220178T1 (ar) |
HU (1) | HUE057987T2 (ar) |
IL (1) | IL273778B (ar) |
JO (1) | JOP20200104A1 (ar) |
LT (1) | LT3707133T (ar) |
MA (1) | MA50561B1 (ar) |
MD (1) | MD3707133T2 (ar) |
MX (1) | MX2020004435A (ar) |
PE (1) | PE20201168A1 (ar) |
PL (1) | PL3707133T3 (ar) |
PT (1) | PT3707133T (ar) |
RS (1) | RS62805B1 (ar) |
SG (1) | SG11202003178PA (ar) |
SI (1) | SI3707133T1 (ar) |
TW (1) | TWI694995B (ar) |
UA (1) | UA126079C2 (ar) |
WO (1) | WO2019089512A1 (ar) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2022533968A (ja) * | 2019-05-23 | 2022-07-27 | ノバルティス アーゲー | ブルトン型チロシンキナーゼ阻害剤を使用したシェーグレン症候群を処置する方法 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2426109B1 (en) * | 2007-10-23 | 2013-12-18 | F. Hoffmann-La Roche AG | Novel kinase inhibitors |
NZ604004A (en) * | 2010-05-07 | 2014-06-27 | Gilead Connecticut Inc | Pyridone and aza-pyridone compounds and methods of use |
AR082590A1 (es) * | 2010-08-12 | 2012-12-19 | Hoffmann La Roche | Inhibidores de la tirosina-quinasa de bruton |
ES2923760T3 (es) | 2011-06-10 | 2022-09-30 | Merck Patent Gmbh | Composiciones y métodos para la producción de compuestos de pirimidina y piridina con actividad inhibidora de BTK |
WO2014093230A2 (en) | 2012-12-10 | 2014-06-19 | Merck Patent Gmbh | Compositions and methods for the production of pyrimidine and pyridine compounds with btk inhibitory activity |
GB2516303A (en) * | 2013-07-18 | 2015-01-21 | Redx Pharma Ltd | Compounds |
US9512084B2 (en) * | 2013-11-29 | 2016-12-06 | Novartis Ag | Amino pyrimidine derivatives |
WO2017059280A1 (en) | 2015-10-02 | 2017-04-06 | The University Of North Carolina At Chapel Hill | Novel pan-tam inhibitors and mer/axl dual inhibitors |
-
2018
- 2018-10-25 TW TW107137682A patent/TWI694995B/zh active
- 2018-10-25 AR ARP180103111A patent/AR113796A1/es unknown
- 2018-10-30 CN CN201880070038.2A patent/CN111278818B/zh active Active
- 2018-10-30 WO PCT/US2018/058104 patent/WO2019089512A1/en unknown
- 2018-10-30 MD MDE20200935T patent/MD3707133T2/ro unknown
- 2018-10-30 US US16/758,219 patent/US11542249B2/en active Active
- 2018-10-30 ES ES18801226T patent/ES2904843T3/es active Active
- 2018-10-30 JP JP2020523393A patent/JP6920553B2/ja active Active
- 2018-10-30 PE PE2020000472A patent/PE20201168A1/es unknown
- 2018-10-30 HR HRP20220178TT patent/HRP20220178T1/hr unknown
- 2018-10-30 LT LTEPPCT/US2018/058104T patent/LT3707133T/lt unknown
- 2018-10-30 MX MX2020004435A patent/MX2020004435A/es unknown
- 2018-10-30 CA CA3080123A patent/CA3080123C/en active Active
- 2018-10-30 PL PL18801226T patent/PL3707133T3/pl unknown
- 2018-10-30 EA EA202090843A patent/EA039398B1/ru unknown
- 2018-10-30 CR CR20200183A patent/CR20200183A/es unknown
- 2018-10-30 JO JOP/2020/0104A patent/JOP20200104A1/ar unknown
- 2018-10-30 RS RS20220028A patent/RS62805B1/sr unknown
- 2018-10-30 HU HUE18801226A patent/HUE057987T2/hu unknown
- 2018-10-30 KR KR1020207012398A patent/KR102410202B1/ko active IP Right Grant
- 2018-10-30 EP EP18801226.4A patent/EP3707133B1/en active Active
- 2018-10-30 DK DK18801226.4T patent/DK3707133T3/da active
- 2018-10-30 MA MA50561A patent/MA50561B1/fr unknown
- 2018-10-30 SI SI201830523T patent/SI3707133T1/sl unknown
- 2018-10-30 PT PT188012264T patent/PT3707133T/pt unknown
- 2018-10-30 BR BR112020006749-0A patent/BR112020006749A2/pt unknown
- 2018-10-30 AU AU2018360478A patent/AU2018360478B2/en active Active
- 2018-10-30 SG SG11202003178PA patent/SG11202003178PA/en unknown
- 2018-10-30 UA UAA202002055A patent/UA126079C2/uk unknown
-
2020
- 2020-04-02 IL IL273778A patent/IL273778B/en unknown
- 2020-04-23 CL CL2020001089A patent/CL2020001089A1/es unknown
- 2020-05-05 EC ECSENADI202024395A patent/ECSP20024395A/es unknown
- 2020-06-01 DO DO2020000103A patent/DOP2020000103A/es unknown
-
2022
- 2022-02-15 CY CY20221100128T patent/CY1124994T1/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PH12018500086A1 (en) | Peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseases | |
MX2023004593A (es) | Inhibidores de tirosina cinasa 2 (tyk2) y usos de los mismos. | |
PH12018500907A1 (en) | Inhibitors of ret | |
PH12017500583A1 (en) | Dihydropyrrolopyridine inhibitors of ror-gamma | |
JOP20200122B1 (ar) | مركبات مفيدة لتثبيط cdk7 | |
PH12016501457A1 (en) | Dihydropyrrolopyridine inhibitors of ror-gamma | |
EA201890047A1 (ru) | Композиции, содержащие бактериальные штаммы | |
EA201790170A1 (ru) | Терапевтические соединения-ингибиторы | |
SG10201804868PA (en) | Compounds for the inhibition of indoleamine-2,3-dioxygenase | |
PH12016501791A1 (en) | Muscarinic receptor agonists | |
GEP20247593B (en) | Compositions and methods of inhibiting masp-3 for the treatment of various diseases and disorders | |
MX2018006632A (es) | Inhibidores biciclicos de peptidilarginina deiminasa 4 (pad4). | |
ZA201907746B (en) | 6-5 fused rings as c5a inhibitors | |
MX2017004618A (es) | Inhibidores de la biosintesis de sulfato de heparano para el tratamiento de enfermedades. | |
MX2017008386A (es) | Administración específica del sitio de un inhibidor de btk. | |
MX2017004808A (es) | Combinaciones que comprenden siponimod y laquinimod para el tratamiento de la esclerosis multiple. | |
MX2019014292A (es) | Anillos 5-5 fusionados como inhibidores c5a. | |
EA202090424A1 (ru) | Бициклические ингибиторы гистондеацетилазы | |
JOP20200104A1 (ar) | مركبات مثبطة لـ btk | |
EA201791450A1 (ru) | 3,5-диаминопиразоловые ингибиторы киназы | |
MX2019005294A (es) | Inhibidores de las interacciones de mtor-deptor y metodos de uso de los mismos. | |
PH12016502480A1 (en) | Compounds, pharmaceutical composition and their use in treating neurodegenerative diseases | |
MX2018006631A (es) | Compuesto para uso en la prevencion y tratamiento de enfermedades neurodegenerativas. | |
MX2017003949A (es) | Derivados peptidicos novedosos y sus usos. | |
MX2019014773A (es) | Inhibidores de ccl2. |